Lixing Zhang
- Cancer Research top 5%
- Cancer-related molecular mechanisms research 5
- Cancer, Hypoxia, and Metabolism 5
- Oncology top 5%
- Cancer Cells and Metastasis 18
- Chemokine receptors and signaling 5
- Immunology top 10%
- Immunotherapy and Immune Responses 8
- Immune cells in cancer 6
- Molecular Biology top 10%
- Analytical Chemistry top 5%
-
- Tuberculosis Research and Epidemiology 5
-
- Supercapacitor Materials and Fabrication 5
- Cited by
- Cancer ResearchOncologyImmunology
- Journals
- Nature Communications (1 paper)SHILAP Revista de lepidopterología (1 paper)PLoS ONE (3 papers)
- Partner nations
- ChinaUnited KingdomUnited States
In The Last Decade
Lixing Zhang
83 papers receiving 2.2k citations
Peers
Comparison fields: 5 of 139
- Cancer Research 407
- Oncology 676
- Immunology 409
- Molecular Biology 1.0k
- Analytical Chemistry 98
Countries citing papers authored by Lixing Zhang
This map shows the geographic impact of Lixing Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lixing Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lixing Zhang more than expected).
Fields of papers citing papers by Lixing Zhang
This network shows the impact of papers produced by Lixing Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lixing Zhang. The network helps show where Lixing Zhang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Lixing Zhang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 6 | |
| 4 | 2024 | 26 | |
| 5 | 2022 | 51 | |
| 6 | 2021 | 50 | |
| 7 | 2021 | 20 | |
| 8 | 2017 | 122 | |
| 9 | 2017 | 86 | |
| 10 | 2016 | 36 | |
| 11 | 2013 | 56 | |
| 12 | 2012 | 82 | |
| 13 | 2011 | 1 | |
| 14 | Structure,Effect and Regulation of the Ubiquitin-Proteasome System | 2008 | 1 |
| 15 | Optimization of Fermentation Technology for Chitinase Production by Aeromonas hydrophila sp. | 2007 | 1 |
| 16 | Radioactive noble gases monitoring for the verification of the Comprehensive Nuclear Test-Ban Treaty | 2004 | 0 |
| 17 | Tuberculosis control priorities defined by using cost-effectiveness and burden of disease. | 2002 | 2 |
| 18 | Methodology for the assessment of burden of smear-positive pulmonary TB and its infectivity. | 2002 | 1 |
| 19 | 2000 | 17 | |
| 20 | Investigation of natural radioactivity level of the waters in Jilin Province | 1992 | 0 |
About Lixing Zhang
Lixing Zhang is a scholar working on Oncology, Cancer Research and Analytical Chemistry, having authored 89 papers that have together received 2.3k indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (18 papers), Immunotherapy and Immune Responses (8 papers), Immune cells in cancer (6 papers), Tuberculosis Research and Epidemiology (5 papers), Supercapacitor Materials and Fabrication (5 papers), Cancer-related molecular mechanisms research (5 papers), Cancer, Hypoxia, and Metabolism (5 papers) and Chemokine receptors and signaling (5 papers). The work is most often cited by research in Cancer Research (407 citations), Oncology (676 citations) and Immunology (409 citations). Lixing Zhang has collaborated with scholars based in China, United Kingdom and United States. Frequent co-authors include Suling Liu, Jinjun Li, Chao Ge, Fangyu Zhao, Xiaojing Ma, Ming Yao, G. F. Kirkbright, Yao Chen, Lei Zhou and Taoyang Chen. Their work appears in journals such as Nature Communications, SHILAP Revista de lepidopterología and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.